epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Furoscix

furosemide

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ (on-body infusor): 80 mg per 10 mL

edema, heart failure-associated

[30 mg/h SC x1h, then 12.5 mg/h SC x4h]
Info: switch to PO when possible

edema, renal disease-associated

[30 mg/h SC x1h, then 12.5 mg/h SC x4h]
Info: switch to PO when possible

renal dosing

[see below]
moderate-severe impairment: consider additional diuretic tx; anuria: contraindicated
HD/PD: not defined, caution advised

hepatic dosing

[see below]
cirrhosis or ascites: not defined, caution advised

Peds Dosing .

Dosage forms:  INJ (on-body infusor): 80 mg per 10 mL

edema, heart failure-associated

[>43 kg]
Dose: 30 mg/h SC x1h, then 12.5 mg/h SC x4h; Info: switch to PO when possible

edema, renal disease-associated

[>43 kg]
Dose: 30 mg/h SC x1h, then 12.5 mg/h SC x4h; Info: switch to PO when possible

renal dosing

[see below]
moderate-severe impairment: consider additional diuretic tx; anuria: contraindicated
HD/PD: not defined, caution advised

hepatic dosing

[see below]
cirrhosis or ascites: not defined, caution advised

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@2c5357bb
  • hypersensitivity to drug or ingredient
  • hypersensitivity to adhesive (on-body infusor form)
  • MRI, concurrent (on-body infusor form)
  • anuria
  • hepatic coma
  • electrolyte imbalance
  • avoid: sun exposure
  • avoid: UV light exposure, artificial
  • caution: hypersensitivity to sulfonamides
  • caution: ototoxic agent use, concurrent
  • caution: elderly patients
  • caution: premature neonates
  • caution: renal impairment
  • caution: renal disease, severe
  • caution: ascites
  • caution: cirrhosis
  • caution: urinary retention
  • caution: arrhythmia
  • caution: gout history
  • caution: SLE
  • caution: diabetes mellitus

Drug Interactions .

Overview

furosemide

loop diuretic

Interaction Characteristics:
  • OAT1 substrate
  • OAT3 substrate
  • antihypertensive agent
  • binds to anion exchange resin/polymer
  • binds to cation exchange resin/polymer
  • binds to polyvalent cations
  • bioavailability increased by hydroxypropyl betadex
  • decreases renal perfusion/fxn
  • diuretic
  • fluid/electrolyte loss
  • hyperglycemic effects
  • hyperuricemic effects
  • hypocalcemia
  • hypokalemia
  • hypomagnesemia
  • hyponatremia
  • ototoxicity
  • photosensitivity
  • thyroid hormone synthesis/metabolism effects

Contraindicated

  • desmopressin
  • Furoscix (furosemide)
    +
    desmopressin
    1 interaction

    Contraindicated

    furosemide + desmopressin

    DESMOPRESSIN INJECTABLE: contraindicated; OTHER DESMOPRESSIN ROUTES: use alternative or monitor sodium, BP: combo may incr. risk of hyponatremia, including life-threatening; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • isocarboxazid
  • Furoscix (furosemide)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    furosemide + isocarboxazid

    contraindicated: combo may incr. risk of hypotension, including orthostasis (additive effects)

Avoid/Use Alternative

  • abiraterone acetate
  • Furoscix (furosemide)
    +
    abiraterone acetate
    1 interaction

    Avoid/Use Alternative

    furosemide + abiraterone acetate

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • albuterol
  • Furoscix (furosemide)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    furosemide + albuterol

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • albuterol inhaled
  • Furoscix (furosemide)
    +
    albuterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + albuterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • aldesleukin
  • Furoscix (furosemide)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    furosemide + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, renal impairment (additive effects)

  • almotriptan
  • Furoscix (furosemide)
    +
    almotriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + almotriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amikacin
  • Furoscix (furosemide)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    furosemide + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amikacin inhaled
  • Furoscix (furosemide)
    +
    amikacin inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + amikacin inhaled

    avoid combo: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • aminolevulinic acid topical
  • Furoscix (furosemide)
    +
    aminolevulinic acid topical
    1 interaction

    Avoid/Use Alternative

    furosemide + aminolevulinic acid topical

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • amphetamine
  • Furoscix (furosemide)
    +
    amphetamine
    1 interaction

    Avoid/Use Alternative

    furosemide + amphetamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Furoscix (furosemide)
    +
    arformoterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + arformoterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • aripiprazole lauroxil
  • Furoscix (furosemide)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    furosemide + aripiprazole lauroxil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • armodafinil
  • Furoscix (furosemide)
    +
    armodafinil
    1 interaction

    Avoid/Use Alternative

    furosemide + armodafinil

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arsenic trioxide
  • Furoscix (furosemide)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    furosemide + arsenic trioxide

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • asciminib
  • Furoscix (furosemide)
    +
    asciminib
    1 interaction

    Avoid/Use Alternative

    furosemide + asciminib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • aspirin
  • Furoscix (furosemide)
    +
    aspirin
    1 interaction

    Avoid/Use Alternative

    furosemide + aspirin

    use alternative or monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • atogepant
  • Furoscix (furosemide)
    +
    atogepant
    1 interaction

    Avoid/Use Alternative

    furosemide + atogepant

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Furoscix (furosemide)
    +
    atomoxetine
    1 interaction

    Avoid/Use Alternative

    furosemide + atomoxetine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • axitinib
  • Furoscix (furosemide)
    +
    axitinib
    1 interaction

    Avoid/Use Alternative

    furosemide + axitinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Furoscix (furosemide)
    +
    benzphetamine
    1 interaction

    Avoid/Use Alternative

    furosemide + benzphetamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • betamethasone
  • Furoscix (furosemide)
    +
    betamethasone
    1 interaction

    Avoid/Use Alternative

    furosemide + betamethasone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • bevacizumab
  • Furoscix (furosemide)
    +
    bevacizumab
    1 interaction

    Avoid/Use Alternative

    furosemide + bevacizumab

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Furoscix (furosemide)
    +
    brigatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + brigatinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • budesonide
  • Furoscix (furosemide)
    +
    budesonide
    1 interaction

    Avoid/Use Alternative

    furosemide + budesonide

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • bumetanide
  • Furoscix (furosemide)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    furosemide + bumetanide

    avoid combo: combo may incr. risk of renal impairment, hyponatremia, hypokalemia, hypomagnesemia, hypocalcemia, tetany, auditory, vestibular and other adverse effects (additive effects, duplicate therapy)

  • bupropion
  • Furoscix (furosemide)
    +
    bupropion
    1 interaction

    Avoid/Use Alternative

    furosemide + bupropion

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cabozantinib
  • Furoscix (furosemide)
    +
    cabozantinib
    1 interaction

    Avoid/Use Alternative

    furosemide + cabozantinib

    use alternative or monitor calcium, BP: combo may incr. risk of hypocalcemia, tetany; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • caffeine
  • Furoscix (furosemide)
    +
    caffeine
    1 interaction

    Avoid/Use Alternative

    furosemide + caffeine

    use alternative or monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine citrate
  • Furoscix (furosemide)
    +
    caffeine citrate
    1 interaction

    Avoid/Use Alternative

    furosemide + caffeine citrate

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Furoscix (furosemide)
    +
    cannabis
    1 interaction

    Avoid/Use Alternative

    furosemide + cannabis

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • carboplatin
  • Furoscix (furosemide)
    +
    carboplatin
    1 interaction

    Avoid/Use Alternative

    furosemide + carboplatin

    use alternative or monitor CBC, renal fxn, magnesium, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, hypomagnesemia, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Furoscix (furosemide)
    +
    carfilzomib
    1 interaction

    Avoid/Use Alternative

    furosemide + carfilzomib

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • clofarabine
  • Furoscix (furosemide)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    furosemide + clofarabine

    avoid furosemide during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, hypotension, other adverse effects (additive effects)

  • copanlisib
  • Furoscix (furosemide)
    +
    copanlisib
    1 interaction

    Avoid/Use Alternative

    furosemide + copanlisib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Furoscix (furosemide)
    +
    corticotropin
    1 interaction

    Avoid/Use Alternative

    furosemide + corticotropin

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • cortisone
  • Furoscix (furosemide)
    +
    cortisone
    1 interaction

    Avoid/Use Alternative

    furosemide + cortisone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • cyclosporine
  • Furoscix (furosemide)
    +
    cyclosporine
    1 interaction

    Avoid/Use Alternative

    furosemide + cyclosporine

    use alternative or monitor renal fxn, magnesium, BP: combo may incr. risk of nephrotoxicity, hypomagnesemia, seizures; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • danazol
  • Furoscix (furosemide)
    +
    danazol
    1 interaction

    Avoid/Use Alternative

    furosemide + danazol

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • Furoscix (furosemide)
    +
    darbepoetin alfa
    1 interaction

    Avoid/Use Alternative

    furosemide + darbepoetin alfa

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • deflazacort
  • Furoscix (furosemide)
    +
    deflazacort
    1 interaction

    Avoid/Use Alternative

    furosemide + deflazacort

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • desvenlafaxine
  • Furoscix (furosemide)
    +
    desvenlafaxine
    1 interaction

    Avoid/Use Alternative

    furosemide + desvenlafaxine

    use alternative or monitor BP, sodium: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • dexamethasone
  • Furoscix (furosemide)
    +
    dexamethasone
    1 interaction

    Avoid/Use Alternative

    furosemide + dexamethasone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • dexmethylphenidate
  • Furoscix (furosemide)
    +
    dexmethylphenidate
    1 interaction

    Avoid/Use Alternative

    furosemide + dexmethylphenidate

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dextroamphetamine
  • Furoscix (furosemide)
    +
    dextroamphetamine
    1 interaction

    Avoid/Use Alternative

    furosemide + dextroamphetamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diethylpropion
  • Furoscix (furosemide)
    +
    diethylpropion
    1 interaction

    Avoid/Use Alternative

    furosemide + diethylpropion

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dihydroergotamine
  • Furoscix (furosemide)
    +
    dihydroergotamine
    1 interaction

    Avoid/Use Alternative

    furosemide + dihydroergotamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxapram
  • Furoscix (furosemide)
    +
    doxapram
    1 interaction

    Avoid/Use Alternative

    furosemide + doxapram

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Furoscix (furosemide)
    +
    dronabinol
    1 interaction

    Avoid/Use Alternative

    furosemide + dronabinol

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • droxidopa
  • Furoscix (furosemide)
    +
    droxidopa
    1 interaction

    Avoid/Use Alternative

    furosemide + droxidopa

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • eletriptan
  • Furoscix (furosemide)
    +
    eletriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + eletriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Furoscix (furosemide)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    furosemide + ephedra

    avoid combo: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Furoscix (furosemide)
    +
    ephedrine injection
    1 interaction

    Avoid/Use Alternative

    furosemide + ephedrine injection

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine oral
  • Furoscix (furosemide)
    +
    ephedrine oral
    1 interaction

    Avoid/Use Alternative

    furosemide + ephedrine oral

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine
  • Furoscix (furosemide)
    +
    epinephrine
    1 interaction

    Avoid/Use Alternative

    furosemide + epinephrine

    use alternative or monitor BP, potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • epinephrine inhaled
  • Furoscix (furosemide)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + epinephrine inhaled

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Furoscix (furosemide)
    +
    epoetin alfa
    1 interaction

    Avoid/Use Alternative

    furosemide + epoetin alfa

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • eptinezumab
  • Furoscix (furosemide)
    +
    eptinezumab
    1 interaction

    Avoid/Use Alternative

    furosemide + eptinezumab

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • erenumab
  • Furoscix (furosemide)
    +
    erenumab
    1 interaction

    Avoid/Use Alternative

    furosemide + erenumab

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ergotamine
  • Furoscix (furosemide)
    +
    ergotamine
    1 interaction

    Avoid/Use Alternative

    furosemide + ergotamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • esketamine
  • Furoscix (furosemide)
    +
    esketamine
    1 interaction

    Avoid/Use Alternative

    furosemide + esketamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Furoscix (furosemide)
    +
    estetrol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    furosemide + estetrol (contraceptive)

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Furoscix (furosemide)
    +
    estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    furosemide + estradiol (contraceptive)

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Furoscix (furosemide)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    furosemide + ethanol (alcoholic beverage)

    use alternative or monitor BP: combo may alter BP control, initially incr. risk of severe hypotension (including orthostasis), followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • ethinyl estradiol (contraceptive)
  • Furoscix (furosemide)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    furosemide + ethinyl estradiol (contraceptive)

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etrasimod
  • Furoscix (furosemide)
    +
    etrasimod
    1 interaction

    Avoid/Use Alternative

    furosemide + etrasimod

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Furoscix (furosemide)
    +
    fenfluramine
    1 interaction

    Avoid/Use Alternative

    furosemide + fenfluramine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fludrocortisone
  • Furoscix (furosemide)
    +
    fludrocortisone
    1 interaction

    Avoid/Use Alternative

    furosemide + fludrocortisone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • formoterol inhaled
  • Furoscix (furosemide)
    +
    formoterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + formoterol inhaled

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia, ECG changes (antagonistic effects; additive effects)

  • fostamatinib
  • Furoscix (furosemide)
    +
    fostamatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + fostamatinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fremanezumab
  • Furoscix (furosemide)
    +
    fremanezumab
    1 interaction

    Avoid/Use Alternative

    furosemide + fremanezumab

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • frovatriptan
  • Furoscix (furosemide)
    +
    frovatriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + frovatriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fruquintinib
  • Furoscix (furosemide)
    +
    fruquintinib
    1 interaction

    Avoid/Use Alternative

    furosemide + fruquintinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • galcanezumab
  • Furoscix (furosemide)
    +
    galcanezumab
    1 interaction

    Avoid/Use Alternative

    furosemide + galcanezumab

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • gentamicin
  • Furoscix (furosemide)
    +
    gentamicin
    1 interaction

    Avoid/Use Alternative

    furosemide + gentamicin

    avoid combo: combo may incr. gentamicin levels, risk of nephrotoxicity, hypocalcemia, tetany, auditory, vestibular, other adverse effects (additive effects)

  • hoodia
  • Furoscix (furosemide)
    +
    hoodia
    1 interaction

    Avoid/Use Alternative

    furosemide + hoodia

    avoid combo: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Furoscix (furosemide)
    +
    hydrocortisone
    1 interaction

    Avoid/Use Alternative

    furosemide + hydrocortisone

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • ibrutinib
  • Furoscix (furosemide)
    +
    ibrutinib
    1 interaction

    Avoid/Use Alternative

    furosemide + ibrutinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ifosfamide
  • Furoscix (furosemide)
    +
    ifosfamide
    1 interaction

    Avoid/Use Alternative

    furosemide + ifosfamide

    use alternative or monitor sodium, CBC, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • immune globulin
  • Furoscix (furosemide)
    +
    immune globulin
    1 interaction

    Avoid/Use Alternative

    furosemide + immune globulin

    use alternative or monitor renal fxn, thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • iodixanol
  • Furoscix (furosemide)
    +
    iodixanol
    1 interaction

    Avoid/Use Alternative

    furosemide + iodixanol

    avoid furosemide prior to iodixanol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • iomeprol
  • Furoscix (furosemide)
    +
    iomeprol
    1 interaction

    Avoid/Use Alternative

    furosemide + iomeprol

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • iopromide
  • Furoscix (furosemide)
    +
    iopromide
    1 interaction

    Avoid/Use Alternative

    furosemide + iopromide

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • ioversol
  • Furoscix (furosemide)
    +
    ioversol
    1 interaction

    Avoid/Use Alternative

    furosemide + ioversol

    avoid furosemide prior to ioversol administration: combo may incr. risk of nephrotoxicity (additive effects)

  • ketamine
  • Furoscix (furosemide)
    +
    ketamine
    1 interaction

    Avoid/Use Alternative

    furosemide + ketamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Furoscix (furosemide)
    +
    lanreotide
    1 interaction

    Avoid/Use Alternative

    furosemide + lanreotide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • leflunomide
  • Furoscix (furosemide)
    +
    leflunomide
    1 interaction

    Avoid/Use Alternative

    furosemide + leflunomide

    use alternative or monitor BP, renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide efficacy (renal transport inhibited; antagonistic effects)

  • lenvatinib
  • Furoscix (furosemide)
    +
    lenvatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + lenvatinib

    use alternative or monitor calcium, BP: combo may incr. risk of hypocalcemia, tetany; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levalbuterol inhaled
  • Furoscix (furosemide)
    +
    levalbuterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + levalbuterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levomilnacipran
  • Furoscix (furosemide)
    +
    levomilnacipran
    1 interaction

    Avoid/Use Alternative

    furosemide + levomilnacipran

    use alternative or monitor BP, sodium: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • levothyroxine
  • Furoscix (furosemide)
    +
    levothyroxine
    1 interaction

    Avoid/Use Alternative

    furosemide + levothyroxine

    use alternative or monitor BP, thyroid fxn if furosemide dose >80 mg: combo may decr. thyroid hormone efficacy; may decr. antihypertensive agent efficacy (carrier protein displacement; antagonistic effects)

  • licorice
  • Furoscix (furosemide)
    +
    licorice
    1 interaction

    Avoid/Use Alternative

    furosemide + licorice

    use alternative or monitor BP, potassium w/ large amounts of licorice: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • liothyronine
  • Furoscix (furosemide)
    +
    liothyronine
    1 interaction

    Avoid/Use Alternative

    furosemide + liothyronine

    use alternative or monitor BP, thyroid fxn if furosemide dose >80 mg: combo may decr. thyroid hormone efficacy; may decr. antihypertensive agent efficacy (carrier protein displacement; antagonistic effects)

  • lisdexamfetamine
  • Furoscix (furosemide)
    +
    lisdexamfetamine
    1 interaction

    Avoid/Use Alternative

    furosemide + lisdexamfetamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lithium
  • Furoscix (furosemide)
    +
    lithium
    1 interaction

    Avoid/Use Alternative

    furosemide + lithium

    use alternative or monitor lithium levels, renal fxn; consider decr. lithium start dose: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lofexidine
  • Furoscix (furosemide)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    furosemide + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lorlatinib
  • Furoscix (furosemide)
    +
    lorlatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + lorlatinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Furoscix (furosemide)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    furosemide + lumacaftor/ ivacaftor

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • luspatercept
  • Furoscix (furosemide)
    +
    luspatercept
    1 interaction

    Avoid/Use Alternative

    furosemide + luspatercept

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mannitol
  • Furoscix (furosemide)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    furosemide + mannitol

    use alternative or monitor renal fxn, sodium, potassium, ECG: combo may incr. mannitol levels, risk of renal impairment, neurotoxicity (including life-threatening), hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia (including life-threatening), seizures, other adverse effects (additive effects)

  • mefenamic acid
  • Furoscix (furosemide)
    +
    mefenamic acid
    1 interaction

    Avoid/Use Alternative

    furosemide + mefenamic acid

    use alternative or monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • methamphetamine
  • Furoscix (furosemide)
    +
    methamphetamine
    1 interaction

    Avoid/Use Alternative

    furosemide + methamphetamine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methoxy polyethylene glycol-epoetin beta
  • Furoscix (furosemide)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Avoid/Use Alternative

    furosemide + methoxy polyethylene glycol-epoetin beta

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Furoscix (furosemide)
    +
    methylergonovine
    1 interaction

    Avoid/Use Alternative

    furosemide + methylergonovine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Furoscix (furosemide)
    +
    methylphenidate
    1 interaction

    Avoid/Use Alternative

    furosemide + methylphenidate

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Furoscix (furosemide)
    +
    methylprednisolone
    1 interaction

    Avoid/Use Alternative

    furosemide + methylprednisolone

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • methyltestosterone
  • Furoscix (furosemide)
    +
    methyltestosterone
    1 interaction

    Avoid/Use Alternative

    furosemide + methyltestosterone

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoclopramide
  • Furoscix (furosemide)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    furosemide + metoclopramide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • midodrine
  • Furoscix (furosemide)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    furosemide + midodrine

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • milnacipran
  • Furoscix (furosemide)
    +
    milnacipran
    1 interaction

    Avoid/Use Alternative

    furosemide + milnacipran

    use alternative or monitor BP, sodium: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • mirabegron
  • Furoscix (furosemide)
    +
    mirabegron
    1 interaction

    Avoid/Use Alternative

    furosemide + mirabegron

    avoid combo: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • modafinil
  • Furoscix (furosemide)
    +
    modafinil
    1 interaction

    Avoid/Use Alternative

    furosemide + modafinil

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naratriptan
  • Furoscix (furosemide)
    +
    naratriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + naratriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naxitamab
  • Furoscix (furosemide)
    +
    naxitamab
    1 interaction

    Avoid/Use Alternative

    furosemide + naxitamab

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • neomycin
  • Furoscix (furosemide)
    +
    neomycin
    1 interaction

    Avoid/Use Alternative

    furosemide + neomycin

    avoid combo: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects if compromised gut wall allows for neomycin absorption (additive effects)

  • neomycin otic
  • Furoscix (furosemide)
    +
    neomycin otic
    1 interaction

    Avoid/Use Alternative

    furosemide + neomycin otic

    use alternative or monitor for ototoxicity, especially if neomycin otic prolonged use: combo may incr. risk of auditory, vestibular adverse effects (additive effects, perforated tympanic membrane may incr. otic neomycin absorption)

  • niraparib
  • Furoscix (furosemide)
    +
    niraparib
    1 interaction

    Avoid/Use Alternative

    furosemide + niraparib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Furoscix (furosemide)
    +
    olodaterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + olodaterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • osilodrostat
  • Furoscix (furosemide)
    +
    osilodrostat
    1 interaction

    Avoid/Use Alternative

    furosemide + osilodrostat

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • oxytocin
  • Furoscix (furosemide)
    +
    oxytocin
    1 interaction

    Avoid/Use Alternative

    furosemide + oxytocin

    use alternative or monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • paromomycin
  • Furoscix (furosemide)
    +
    paromomycin
    1 interaction

    Avoid/Use Alternative

    furosemide + paromomycin

    if compromised gut wall allows for paromomycin absorption, use alternative or monitor renal fxn, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pazopanib
  • Furoscix (furosemide)
    +
    pazopanib
    1 interaction

    Avoid/Use Alternative

    furosemide + pazopanib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Furoscix (furosemide)
    +
    pexidartinib
    1 interaction

    Avoid/Use Alternative

    furosemide + pexidartinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Furoscix (furosemide)
    +
    phendimetrazine
    1 interaction

    Avoid/Use Alternative

    furosemide + phendimetrazine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Furoscix (furosemide)
    +
    phentermine
    1 interaction

    Avoid/Use Alternative

    furosemide + phentermine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Furoscix (furosemide)
    +
    phenylephrine
    1 interaction

    Avoid/Use Alternative

    furosemide + phenylephrine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine injection
  • Furoscix (furosemide)
    +
    phenylephrine injection
    1 interaction

    Avoid/Use Alternative

    furosemide + phenylephrine injection

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • plazomicin
  • Furoscix (furosemide)
    +
    plazomicin
    1 interaction

    Avoid/Use Alternative

    furosemide + plazomicin

    use alternative or monitor renal fxn, plazomicin levels, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • ponatinib
  • Furoscix (furosemide)
    +
    ponatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + ponatinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • porfimer
  • Furoscix (furosemide)
    +
    porfimer
    1 interaction

    Avoid/Use Alternative

    furosemide + porfimer

    avoid combo: combo may incr. risk of photosensitivity reaction (additive effects)

  • pralsetinib
  • Furoscix (furosemide)
    +
    pralsetinib
    1 interaction

    Avoid/Use Alternative

    furosemide + pralsetinib

    use alternative or monitor calcium, BP: combo may incr. risk of hypocalcemia, tetany; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • prednisolone
  • Furoscix (furosemide)
    +
    prednisolone
    1 interaction

    Avoid/Use Alternative

    furosemide + prednisolone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • prednisone
  • Furoscix (furosemide)
    +
    prednisone
    1 interaction

    Avoid/Use Alternative

    furosemide + prednisone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • pseudoephedrine
  • Furoscix (furosemide)
    +
    pseudoephedrine
    1 interaction

    Avoid/Use Alternative

    furosemide + pseudoephedrine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quetiapine
  • Furoscix (furosemide)
    +
    quetiapine
    1 interaction

    Avoid/Use Alternative

    furosemide + quetiapine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antihypertensive agent efficacy (peds patients) (additive effects; antagonistic effects)

  • ramucirumab
  • Furoscix (furosemide)
    +
    ramucirumab
    1 interaction

    Avoid/Use Alternative

    furosemide + ramucirumab

    use alternative or monitor sodium, BP: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • regorafenib
  • Furoscix (furosemide)
    +
    regorafenib
    1 interaction

    Avoid/Use Alternative

    furosemide + regorafenib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • rimegepant
  • Furoscix (furosemide)
    +
    rimegepant
    1 interaction

    Avoid/Use Alternative

    furosemide + rimegepant

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ripretinib
  • Furoscix (furosemide)
    +
    ripretinib
    1 interaction

    Avoid/Use Alternative

    furosemide + ripretinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • rizatriptan
  • Furoscix (furosemide)
    +
    rizatriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + rizatriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ropinirole
  • Furoscix (furosemide)
    +
    ropinirole
    1 interaction

    Avoid/Use Alternative

    furosemide + ropinirole

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • rotigotine transdermal
  • Furoscix (furosemide)
    +
    rotigotine transdermal
    1 interaction

    Avoid/Use Alternative

    furosemide + rotigotine transdermal

    use alternative or monitor BP: combo may alter blood pressure control (antagonistic effects, additive effects)

  • salmeterol inhaled
  • Furoscix (furosemide)
    +
    salmeterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + salmeterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • selpercatinib
  • Furoscix (furosemide)
    +
    selpercatinib
    1 interaction

    Avoid/Use Alternative

    furosemide + selpercatinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • siponimod
  • Furoscix (furosemide)
    +
    siponimod
    1 interaction

    Avoid/Use Alternative

    furosemide + siponimod

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sorafenib
  • Furoscix (furosemide)
    +
    sorafenib
    1 interaction

    Avoid/Use Alternative

    furosemide + sorafenib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • streptomycin
  • Furoscix (furosemide)
    +
    streptomycin
    1 interaction

    Avoid/Use Alternative

    furosemide + streptomycin

    avoid combo: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • sumatriptan
  • Furoscix (furosemide)
    +
    sumatriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + sumatriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sunitinib
  • Furoscix (furosemide)
    +
    sunitinib
    1 interaction

    Avoid/Use Alternative

    furosemide + sunitinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tacrolimus
  • Furoscix (furosemide)
    +
    tacrolimus
    1 interaction

    Avoid/Use Alternative

    furosemide + tacrolimus

    use alternative or monitor tacrolimus levels, renal fxn, magnesium, BP: combo may incr. tacrolimus levels, risk of nephrotoxicity, hypomagnesemia, other adverse effects; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tagraxofusp
  • Furoscix (furosemide)
    +
    tagraxofusp
    1 interaction

    Avoid/Use Alternative

    furosemide + tagraxofusp

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • terbutaline
  • Furoscix (furosemide)
    +
    terbutaline
    1 interaction

    Avoid/Use Alternative

    furosemide + terbutaline

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • teriflunomide
  • Furoscix (furosemide)
    +
    teriflunomide
    1 interaction

    Avoid/Use Alternative

    furosemide + teriflunomide

    use alternative or monitor renal fxn, BP: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic, antihypertensive effects (renal transport inhibited; antagonistic effects)

  • testosterone
  • Furoscix (furosemide)
    +
    testosterone
    1 interaction

    Avoid/Use Alternative

    furosemide + testosterone

    avoid combo: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thyroid
  • Furoscix (furosemide)
    +
    thyroid
    1 interaction

    Avoid/Use Alternative

    furosemide + thyroid

    use alternative or monitor BP, thyroid fxn if furosemide dose >80 mg: combo may decr. thyroid hormone efficacy; may decr. antihypertensive agent efficacy (carrier protein displacement; antagonistic effects)

  • tivozanib
  • Furoscix (furosemide)
    +
    tivozanib
    1 interaction

    Avoid/Use Alternative

    furosemide + tivozanib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tobramycin
  • Furoscix (furosemide)
    +
    tobramycin
    1 interaction

    Avoid/Use Alternative

    furosemide + tobramycin

    use alternative or monitor tobramycin levels, renal fxn, electrolytes, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, hypocalcemia, tetany, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Furoscix (furosemide)
    +
    tobramycin inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + tobramycin inhaled

    avoid combo: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • trametinib
  • Furoscix (furosemide)
    +
    trametinib
    1 interaction

    Avoid/Use Alternative

    furosemide + trametinib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Furoscix (furosemide)
    +
    triamcinolone
    1 interaction

    Avoid/Use Alternative

    furosemide + triamcinolone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • ubrogepant
  • Furoscix (furosemide)
    +
    ubrogepant
    1 interaction

    Avoid/Use Alternative

    furosemide + ubrogepant

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vadadustat
  • Furoscix (furosemide)
    +
    vadadustat
    1 interaction

    Avoid/Use Alternative

    furosemide + vadadustat

    use alternative or monitor renal fxn, BP: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects; may decr. antihypertensive agent efficacy (renal transport inhibited; antagonistic effects)

  • vamorolone
  • Furoscix (furosemide)
    +
    vamorolone
    1 interaction

    Avoid/Use Alternative

    furosemide + vamorolone

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • vandetanib
  • Furoscix (furosemide)
    +
    vandetanib
    1 interaction

    Avoid/Use Alternative

    furosemide + vandetanib

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vasopressin
  • Furoscix (furosemide)
    +
    vasopressin
    1 interaction

    Avoid/Use Alternative

    furosemide + vasopressin

    use alternative or monitor BP, sodium: combo may incr. risk of hyponatremia; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • venlafaxine
  • Furoscix (furosemide)
    +
    venlafaxine
    1 interaction

    Avoid/Use Alternative

    furosemide + venlafaxine

    use alternative or monitor BP, sodium: combo may incr. risk of hyponatremia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • vilanterol inhaled
  • Furoscix (furosemide)
    +
    vilanterol inhaled
    1 interaction

    Avoid/Use Alternative

    furosemide + vilanterol inhaled

    use alternative or monitor BP, potassium: combo may incr. risk of hypokalemia, ECG changes; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • viloxazine
  • Furoscix (furosemide)
    +
    viloxazine
    1 interaction

    Avoid/Use Alternative

    furosemide + viloxazine

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • voclosporin
  • Furoscix (furosemide)
    +
    voclosporin
    1 interaction

    Avoid/Use Alternative

    furosemide + voclosporin

    use alternative or monitor renal fxn, BP: combo may incr. risk of nephrotoxicity; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • yohimbe
  • Furoscix (furosemide)
    +
    yohimbe
    1 interaction

    Avoid/Use Alternative

    furosemide + yohimbe

    use alternative or monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • zavegepant
  • Furoscix (furosemide)
    +
    zavegepant
    1 interaction

    Avoid/Use Alternative

    furosemide + zavegepant

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ziv-aflibercept
  • Furoscix (furosemide)
    +
    ziv-aflibercept
    1 interaction

    Avoid/Use Alternative

    furosemide + ziv-aflibercept

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zolmitriptan
  • Furoscix (furosemide)
    +
    zolmitriptan
    1 interaction

    Avoid/Use Alternative

    furosemide + zolmitriptan

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Monitor/Modify Tx

  • acarbose
  • Furoscix (furosemide)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    furosemide + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acetazolamide
  • Furoscix (furosemide)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    furosemide + acetazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • acyclovir
  • Furoscix (furosemide)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    furosemide + acyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Furoscix (furosemide)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    furosemide + adefovir dipivoxil

    monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased, additive effects)

  • alendronate
  • Furoscix (furosemide)
    +
    alendronate
    1 interaction

    Monitor/Modify Tx

    furosemide + alendronate

    monitor calcium: combo may incr. risk of hypocalcemia, tetany (additive effects)

  • alfentanil
  • Furoscix (furosemide)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    furosemide + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • alfuzosin
  • Furoscix (furosemide)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    furosemide + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Furoscix (furosemide)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    furosemide + aliskiren

    monitor renal fxn: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • aloe
  • Furoscix (furosemide)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    furosemide + aloe

    monitor potassium w/ aloe laxative doses: combo may incr. risk of hypokalemia (additive effects)

  • alogliptin
  • Furoscix (furosemide)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    furosemide + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Furoscix (furosemide)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    furosemide + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Furoscix (furosemide)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    furosemide + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Furoscix (furosemide)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    furosemide + amifostine

    D/C furosemide 24h before amifostine admin.; monitor BP, calcium: combo may incr. risk of severe hypotension (including syncope), hypocalcemia, tetany (additive effects)

  • amiloride
  • Furoscix (furosemide)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    furosemide + amiloride

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • amitriptyline
  • Furoscix (furosemide)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    furosemide + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Furoscix (furosemide)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    furosemide + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amphotericin
  • Furoscix (furosemide)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    furosemide + amphotericin

    monitor renal fxn, magnesium, potassium, ECG, ototoxicity, ototoxicity: combo may incr. risk of nephrotoxicity, hypomagnesemia, hypokalemia, cardiac arrhythmias, auditory, vestibular adverse effects (additive effects)

  • anthrax immune globulin
  • Furoscix (furosemide)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    furosemide + anthrax immune globulin

    monitor renal fxn; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • apomorphine
  • Furoscix (furosemide)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    furosemide + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Furoscix (furosemide)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension (additive effects)

  • apremilast
  • Furoscix (furosemide)
    +
    apremilast
    1 interaction

    Monitor/Modify Tx

    furosemide + apremilast

    monitor electrolytes, volume status: combo may incr. risk of electrolyte abnormalities, dehydration, other adverse effects (additive effects)

  • aripiprazole bimonthly injection
  • Furoscix (furosemide)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    furosemide + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole monthly injection
  • Furoscix (furosemide)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    furosemide + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Furoscix (furosemide)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    furosemide + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • articaine
  • Furoscix (furosemide)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    furosemide + articaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • asenapine
  • Furoscix (furosemide)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    furosemide + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • asparaginase
  • Furoscix (furosemide)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    furosemide + asparaginase

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • atropine ophthalmic
  • Furoscix (furosemide)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + atropine ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • auranofin
  • Furoscix (furosemide)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    furosemide + auranofin

    monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avanafil
  • Furoscix (furosemide)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    furosemide + avanafil

    monitor BP, ototoxicity: combo may incr. risk of auditory, vestibular adverse effects, hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Furoscix (furosemide)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    furosemide + azilsartan medoxomil

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • balsalazide
  • Furoscix (furosemide)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    furosemide + balsalazide

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • benazepril
  • Furoscix (furosemide)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    furosemide + benazepril

    monitor renal fxn, sodium, BP: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • berberine
  • Furoscix (furosemide)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    furosemide + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • betaxolol ophthalmic
  • Furoscix (furosemide)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bethanechol
  • Furoscix (furosemide)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    furosemide + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bexagliflozin
  • Furoscix (furosemide)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + bexagliflozin

    monitor volume status, BP, renal fxn, electrolytes, glucose: combo may incr. risk of hypovolemia, dehydration, renal impairment, electrolyte abnormalities, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bismuth subsalicylate
  • Furoscix (furosemide)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    furosemide + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bortezomib
  • Furoscix (furosemide)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    furosemide + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • botulism immune globulin
  • Furoscix (furosemide)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    furosemide + botulism immune globulin

    monitor renal fxn; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • brexpiprazole
  • Furoscix (furosemide)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Furoscix (furosemide)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Furoscix (furosemide)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    furosemide + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Furoscix (furosemide)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    furosemide + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of hypotension (including orthostasis, syncope); may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bupivacaine
  • Furoscix (furosemide)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    furosemide + bupivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bupivacaine liposomal
  • Furoscix (furosemide)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    furosemide + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • buprenorphine
  • Furoscix (furosemide)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    furosemide + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • butalbital
  • Furoscix (furosemide)
    +
    butalbital
    1 interaction

    Monitor/Modify Tx

    furosemide + butalbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • butorphanol
  • Furoscix (furosemide)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    furosemide + butorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • cabergoline
  • Furoscix (furosemide)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    furosemide + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabotegravir
  • Furoscix (furosemide)
    +
    cabotegravir
    1 interaction

    Monitor/Modify Tx

    furosemide + cabotegravir

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport inhibited)

  • calcitonin-salmon
  • Furoscix (furosemide)
    +
    calcitonin-salmon
    1 interaction

    Monitor/Modify Tx

    furosemide + calcitonin-salmon

    monitor calcium: combo may incr. risk of hypocalcemia, tetany, seizures (additive effects)

  • canagliflozin
  • Furoscix (furosemide)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + canagliflozin

    monitor volume status, renal fxn, BP, glucose: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Furoscix (furosemide)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    furosemide + candesartan cilexetil

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • capecitabine
  • Furoscix (furosemide)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    furosemide + capecitabine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • captopril
  • Furoscix (furosemide)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    furosemide + captopril

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • carbamazepine
  • Furoscix (furosemide)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    furosemide + carbamazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • cariprazine
  • Furoscix (furosemide)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    furosemide + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Furoscix (furosemide)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cefepime
  • Furoscix (furosemide)
    +
    cefepime
    1 interaction

    Monitor/Modify Tx

    furosemide + cefepime

    monitor renal fxn: combo may incr. cefepime levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • cefpodoxime
  • Furoscix (furosemide)
    +
    cefpodoxime
    1 interaction

    Monitor/Modify Tx

    furosemide + cefpodoxime

    monitor renal fxn: combo may incr. cefpodoxime levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • cefprozil
  • Furoscix (furosemide)
    +
    cefprozil
    1 interaction

    Monitor/Modify Tx

    furosemide + cefprozil

    monitor renal fxn: combo may incr. cefprozil levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • ceftazidime
  • Furoscix (furosemide)
    +
    ceftazidime
    1 interaction

    Monitor/Modify Tx

    furosemide + ceftazidime

    monitor renal fxn: combo may incr. ceftazidime levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • cefuroxime sodium
  • Furoscix (furosemide)
    +
    cefuroxime sodium
    1 interaction

    Monitor/Modify Tx

    furosemide + cefuroxime sodium

    monitor renal fxn: combo may incr. cefuroxime levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • celecoxib
  • Furoscix (furosemide)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    furosemide + celecoxib

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • cetuximab
  • Furoscix (furosemide)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    furosemide + cetuximab

    monitor potassium, calcium, magnesium: combo may incr. risk of hypokalemia, hypocalcemia, hypomagnesemia, tetany (additive effects)

  • chloroprocaine
  • Furoscix (furosemide)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    furosemide + chloroprocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • chloroquine
  • Furoscix (furosemide)
    +
    chloroquine
    1 interaction

    Monitor/Modify Tx

    furosemide + chloroquine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • chlorothiazide
  • Furoscix (furosemide)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    furosemide + chlorothiazide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hyponatremia, seizures, hypokalemia, hypomagnesemia, other adverse effects (additive effects, duplicate therapy)

  • chlorpromazine
  • Furoscix (furosemide)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    furosemide + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Furoscix (furosemide)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    furosemide + chlorthalidone

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia (additive effects)

  • cholestyramine
  • Furoscix (furosemide)
    +
    cholestyramine
    1 interaction

    Monitor/Modify Tx

    furosemide + cholestyramine

    give oral furosemide at least 1h before or 4-6h after each cholestyramine dose: combo may decr. furosemide levels, efficacy (absorption decreased/delayed)

  • cidofovir
  • Furoscix (furosemide)
    +
    cidofovir
    1 interaction

    Monitor/Modify Tx

    furosemide + cidofovir

    monitor CBC, renal fxn: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • cilostazol
  • Furoscix (furosemide)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    furosemide + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cinacalcet
  • Furoscix (furosemide)
    +
    cinacalcet
    1 interaction

    Monitor/Modify Tx

    furosemide + cinacalcet

    monitor calcium, ECG: combo may incr. risk of severe hypocalcemia (including life-threatening), QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • cisplatin
  • Furoscix (furosemide)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    furosemide + cisplatin

    monitor CBC, renal fxn, ototoxicity, potassium, sodium, calcium: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, hypokalemia, hyponatremia, hypocalcemia, tetany, other adverse effects (additive effects)

  • citalopram
  • Furoscix (furosemide)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    furosemide + citalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • cladribine oral
  • Furoscix (furosemide)
    +
    cladribine oral
    1 interaction

    Monitor/Modify Tx

    furosemide + cladribine oral

    separate cladribine admin. from furosemide by at least 3h: combo may incr. furosemide bioavailability, risk of adverse effects (hydroxypropyl betadex in cladribine tablet may form more soluble complex with furosemide)

  • clindamycin
  • Furoscix (furosemide)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    furosemide + clindamycin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clomipramine
  • Furoscix (furosemide)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    furosemide + clomipramine

    monitor BP, sodium: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • clonidine
  • Furoscix (furosemide)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    furosemide + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Furoscix (furosemide)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    furosemide + clozapine

    monitor BP, HR: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cocaine
  • Furoscix (furosemide)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    furosemide + cocaine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • codeine
  • Furoscix (furosemide)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    furosemide + codeine

    monitor BP: combo may decr. furosemide efficacy; may incr. risk of severe hypotension, including orthostasis, syncope (antagonistic effects, opioids may induce antidiuretic hormone release; additive effects)

  • coenzyme Q-10
  • Furoscix (furosemide)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    furosemide + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • colesevelam
  • Furoscix (furosemide)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    furosemide + colesevelam

    monitor glucose in type 2 diabetes mellitus pts; give oral furosemide at least 4h before each colesevelam dose: combo may decr. furosemide levels, efficacy; may decr. antidiabetic agent efficacy (absorption decreased/delayed; antagonistic effects)

  • colestipol
  • Furoscix (furosemide)
    +
    colestipol
    1 interaction

    Monitor/Modify Tx

    furosemide + colestipol

    give oral furosemide at least 1h before or 4h after each colestipol dose: combo may decr. furosemide levels, efficacy (absorption decreased/delayed)

  • colistimethate
  • Furoscix (furosemide)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    furosemide + colistimethate

    monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • copper histidinate
  • Furoscix (furosemide)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    furosemide + copper histidinate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • creatine
  • Furoscix (furosemide)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    furosemide + creatine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • crizotinib
  • Furoscix (furosemide)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    furosemide + crizotinib

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • cyclophosphamide
  • Furoscix (furosemide)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    furosemide + cyclophosphamide

    monitor CBC, renal, cardiac fxn, sodium: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, hyponatremia (including life-threatening), other adverse effects (additive effects)

  • cytomegalovirus immune globulin
  • Furoscix (furosemide)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    furosemide + cytomegalovirus immune globulin

    monitor renal fxn; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • dapagliflozin
  • Furoscix (furosemide)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + dapagliflozin

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • decitabine
  • Furoscix (furosemide)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    furosemide + decitabine

    monitor potassium w/ IV decitabine use: combo may incr. risk of hypokalemia (additive effects)

  • deferasirox
  • Furoscix (furosemide)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    furosemide + deferasirox

    monitor CBC, renal fxn, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Furoscix (furosemide)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    furosemide + deferoxamine

    monitor renal fxn, ototoxicity: combo may incr. risk of nephrotoxicity, auditory, vestibular adverse effects (additive effects)

  • denileukin diftitox
  • Furoscix (furosemide)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    furosemide + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • denosumab
  • Furoscix (furosemide)
    +
    denosumab
    1 interaction

    Monitor/Modify Tx

    furosemide + denosumab

    monitor calcium: combo may incr. risk of severe hypocalcemia (including life-threatening), tetany (additive effects)

  • desflurane
  • Furoscix (furosemide)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    furosemide + desflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • desipramine
  • Furoscix (furosemide)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    furosemide + desipramine

    monitor BP, sodium: combo may incr. risk of hypotension (including orthostasis), hyponatremia (additive effects)

  • dexlansoprazole
  • Furoscix (furosemide)
    +
    dexlansoprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + dexlansoprazole

    monitor magnesium, especially w/ dexlansoprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • dexmedetomidine
  • Furoscix (furosemide)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    furosemide + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Furoscix (furosemide)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    furosemide + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • diazoxide
  • Furoscix (furosemide)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    furosemide + diazoxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • dichlorphenamide
  • Furoscix (furosemide)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    furosemide + dichlorphenamide

    monitor renal fxn, potassium: combo may incr. furosemide levels, risk of nephrotoxicity, hypokalemia, other adverse effects; may decr. furosemide natriuretic effects (renal transport possibly inhibited, additive effects)

  • diclofenac
  • Furoscix (furosemide)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    furosemide + diclofenac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • diclofenac topical
  • Furoscix (furosemide)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    furosemide + diclofenac topical

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • diflunisal
  • Furoscix (furosemide)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    furosemide + diflunisal

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • digoxin
  • Furoscix (furosemide)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    furosemide + digoxin

    monitor electrolytes: combo may incr. risk of hypokalemia, digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities)

  • dihydrocodeine
  • Furoscix (furosemide)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    furosemide + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • dinutuximab
  • Furoscix (furosemide)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    furosemide + dinutuximab

    monitor BP, potassium, sodium, calcium: combo may incr. risk of severe hypotension, severe hyponatremia, hypokalemia, hypocalcemia, tetany (additive effects)

  • dipyridamole
  • Furoscix (furosemide)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    furosemide + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • docetaxel
  • Furoscix (furosemide)
    +
    docetaxel
    1 interaction

    Monitor/Modify Tx

    furosemide + docetaxel

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • dofetilide
  • Furoscix (furosemide)
    +
    dofetilide
    1 interaction

    Monitor/Modify Tx

    furosemide + dofetilide

    monitor ECG, electrolytes: combo may incr. risk of QT prolongation, cardiac arrhythmias (electrolyte abnormalities)

  • doxazosin
  • Furoscix (furosemide)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    furosemide + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Furoscix (furosemide)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    furosemide + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dulaglutide
  • Furoscix (furosemide)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    furosemide + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Furoscix (furosemide)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    furosemide + duloxetine

    monitor BP, sodium: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • eflornithine
  • Furoscix (furosemide)
    +
    eflornithine
    1 interaction

    Monitor/Modify Tx

    furosemide + eflornithine

    monitor ototoxicity s/sx: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • emapalumab
  • Furoscix (furosemide)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    furosemide + emapalumab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • empagliflozin
  • Furoscix (furosemide)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + empagliflozin

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • enalapril
  • Furoscix (furosemide)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    furosemide + enalapril

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • enalaprilat
  • Furoscix (furosemide)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    furosemide + enalaprilat

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • entacapone
  • Furoscix (furosemide)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    furosemide + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Furoscix (furosemide)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    furosemide + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • epoprostenol
  • Furoscix (furosemide)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    furosemide + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ertugliflozin
  • Furoscix (furosemide)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + ertugliflozin

    monitor BP, glucose, volume status, renal fxn: combo may incr. risk of hypovolemia, renal impairment, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • escitalopram
  • Furoscix (furosemide)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    furosemide + escitalopram

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • eslicarbazepine acetate
  • Furoscix (furosemide)
    +
    eslicarbazepine acetate
    1 interaction

    Monitor/Modify Tx

    furosemide + eslicarbazepine acetate

    monitor sodium: combo may incr. risk of hyponatremia (including life-threatening), seizures (additive effects)

  • esomeprazole
  • Furoscix (furosemide)
    +
    esomeprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + esomeprazole

    monitor magnesium, especially w/ esomeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • etelcalcetide
  • Furoscix (furosemide)
    +
    etelcalcetide
    1 interaction

    Monitor/Modify Tx

    furosemide + etelcalcetide

    monitor calcium, ECG: combo may incr. risk of severe hypocalcemia (including life-threatening), tetany, QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • ethanol injection
  • Furoscix (furosemide)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    furosemide + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • etodolac
  • Furoscix (furosemide)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    furosemide + etodolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • etripamil nasal
  • Furoscix (furosemide)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    furosemide + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • exenatide
  • Furoscix (furosemide)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    furosemide + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • febuxostat
  • Furoscix (furosemide)
    +
    febuxostat
    1 interaction

    Monitor/Modify Tx

    furosemide + febuxostat

    monitor uric acid levels: combo may decr. febuxostat efficacy (antagonistic effects)

  • fenoprofen
  • Furoscix (furosemide)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    furosemide + fenoprofen

    monitor renal fxn, ototoxicity, BP: combo may incr. risk of renal impairment, auditory, vestibular adverse effects; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • fentanyl
  • Furoscix (furosemide)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    furosemide + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • ferumoxytol
  • Furoscix (furosemide)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    furosemide + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • fexinidazole
  • Furoscix (furosemide)
    +
    fexinidazole
    1 interaction

    Monitor/Modify Tx

    furosemide + fexinidazole

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport possibly inhibited)

  • fingolimod
  • Furoscix (furosemide)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    furosemide + fingolimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • flaxseed
  • Furoscix (furosemide)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    furosemide + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flibanserin
  • Furoscix (furosemide)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    furosemide + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • flucytosine
  • Furoscix (furosemide)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    furosemide + flucytosine

    monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludarabine
  • Furoscix (furosemide)
    +
    fludarabine
    1 interaction

    Monitor/Modify Tx

    furosemide + fludarabine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • fluoxetine
  • Furoscix (furosemide)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    furosemide + fluoxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • fluphenazine
  • Furoscix (furosemide)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    furosemide + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurbiprofen
  • Furoscix (furosemide)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    furosemide + flurbiprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • fluvoxamine
  • Furoscix (furosemide)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    furosemide + fluvoxamine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • foscarnet
  • Furoscix (furosemide)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    furosemide + foscarnet

    monitor CBC, renal fxn, calcium, magnesium, potassium, ECG: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, severe hypocalcemia, hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias, tetany, seizures, other adverse effects (additive effects)

  • fosfomycin injection
  • Furoscix (furosemide)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    furosemide + fosfomycin injection

    monitor potassium, calcium: combo may incr. risk of hypokalemia, hypocalcemia (additive effects)

  • fosinopril
  • Furoscix (furosemide)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    furosemide + fosinopril

    monitor renal fxn, BP, sodium: combo may incr. risk of renal impairment, hypotension, hyponatremia (additive effects)

  • foslevodopa
  • Furoscix (furosemide)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    furosemide + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ganciclovir
  • Furoscix (furosemide)
    +
    ganciclovir
    1 interaction

    Monitor/Modify Tx

    furosemide + ganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • garlic
  • Furoscix (furosemide)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    furosemide + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gemfibrozil
  • Furoscix (furosemide)
    +
    gemfibrozil
    1 interaction

    Monitor/Modify Tx

    furosemide + gemfibrozil

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport inhibited)

  • gilteritinib
  • Furoscix (furosemide)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    furosemide + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • glimepiride
  • Furoscix (furosemide)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    furosemide + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Furoscix (furosemide)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    furosemide + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Furoscix (furosemide)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    furosemide + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Furoscix (furosemide)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    furosemide + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Furoscix (furosemide)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    furosemide + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydralazine
  • Furoscix (furosemide)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    furosemide + hydralazine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • hydrochlorothiazide
  • Furoscix (furosemide)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    furosemide + hydrochlorothiazide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, hypomagnesemia, cardiac arrhythmias (additive effects)

  • hydrocodone
  • Furoscix (furosemide)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    furosemide + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydromorphone
  • Furoscix (furosemide)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    furosemide + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • hydroxocobalamin IV
  • Furoscix (furosemide)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    furosemide + hydroxocobalamin IV

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibandronate
  • Furoscix (furosemide)
    +
    ibandronate
    1 interaction

    Monitor/Modify Tx

    furosemide + ibandronate

    monitor calcium: combo may incr. risk of hypocalcemia, tetany (additive effects)

  • ibuprofen
  • Furoscix (furosemide)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    furosemide + ibuprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • ibuprofen lysine
  • Furoscix (furosemide)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    furosemide + ibuprofen lysine

    monitor renal fxn: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • iloperidone
  • Furoscix (furosemide)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    furosemide + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Furoscix (furosemide)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    furosemide + iloprost

    monitor BP; consider holding furosemide during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Furoscix (furosemide)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    furosemide + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • indapamide
  • Furoscix (furosemide)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    furosemide + indapamide

    monitor renal fxn, electrolytes: combo may incr. risk of renal impairment, severe hyponatremia, hypokalemia, hypomagnesemia, other adverse effects (additive effects, duplicate therapy)

  • indomethacin
  • Furoscix (furosemide)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    furosemide + indomethacin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • insulin
  • Furoscix (furosemide)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    furosemide + insulin

    monitor glucose, potassium: combo may incr. risk of hypokalemia; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • iohexol
  • Furoscix (furosemide)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    furosemide + iohexol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iopamidol
  • Furoscix (furosemide)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    furosemide + iopamidol

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iothalamate meglumine
  • Furoscix (furosemide)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    furosemide + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity (additive effects)

  • irbesartan
  • Furoscix (furosemide)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    furosemide + irbesartan

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • iron sucrose
  • Furoscix (furosemide)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    furosemide + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Furoscix (furosemide)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    furosemide + isoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoproterenol
  • Furoscix (furosemide)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    furosemide + isoproterenol

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • isosorbide dinitrate
  • Furoscix (furosemide)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    furosemide + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Furoscix (furosemide)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    furosemide + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isotretinoin
  • Furoscix (furosemide)
    +
    isotretinoin
    1 interaction

    Monitor/Modify Tx

    furosemide + isotretinoin

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • itraconazole
  • Furoscix (furosemide)
    +
    itraconazole
    1 interaction

    Monitor/Modify Tx

    furosemide + itraconazole

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • ketoprofen
  • Furoscix (furosemide)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    furosemide + ketoprofen

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • ketorolac
  • Furoscix (furosemide)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    furosemide + ketorolac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • landiolol
  • Furoscix (furosemide)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    furosemide + landiolol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • lansoprazole
  • Furoscix (furosemide)
    +
    lansoprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + lansoprazole

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • lenalidomide
  • Furoscix (furosemide)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    furosemide + lenalidomide

    monitor potassium, calcium: combo may incr. risk of hypokalemia, hypocalcemia, tetany (additive effects)

  • levobunolol ophthalmic
  • Furoscix (furosemide)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • levodopa
  • Furoscix (furosemide)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    furosemide + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Furoscix (furosemide)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    furosemide + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • lidocaine
  • Furoscix (furosemide)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    furosemide + lidocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • linagliptin
  • Furoscix (furosemide)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    furosemide + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • linezolid
  • Furoscix (furosemide)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    furosemide + linezolid

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • liraglutide
  • Furoscix (furosemide)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    furosemide + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Furoscix (furosemide)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    furosemide + lisinopril

    monitor renal fxn, sodium, BP; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia, hypontension (additive effects)

  • lixisenatide
  • Furoscix (furosemide)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    furosemide + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lomustine
  • Furoscix (furosemide)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    furosemide + lomustine

    monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • losartan
  • Furoscix (furosemide)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    furosemide + losartan

    monitor BP, renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, renal impairment (additive effects)

  • loxapine
  • Furoscix (furosemide)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    furosemide + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Furoscix (furosemide)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    furosemide + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumateperone
  • Furoscix (furosemide)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    furosemide + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Furoscix (furosemide)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    furosemide + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Furoscix (furosemide)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    furosemide + lutetium Lu 177 vipivotide tetraxetan

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Furoscix (furosemide)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    furosemide + magnesium citrate

    monitor renal fxn, volume status, sodium, potassium, consider monitoring ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, renal impairment, dehydration, other adverse effects (additive effects)

  • magnesium salicylate
  • Furoscix (furosemide)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    furosemide + magnesium salicylate

    monitor renal fxn, BP w/ high-dose magnesium salicylate: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • magnesium sulfate
  • Furoscix (furosemide)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    furosemide + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Furoscix (furosemide)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    furosemide + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meclofenamate
  • Furoscix (furosemide)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    furosemide + meclofenamate

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • meloxicam
  • Furoscix (furosemide)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    furosemide + meloxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • meperidine
  • Furoscix (furosemide)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    furosemide + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • mepivacaine
  • Furoscix (furosemide)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    furosemide + mepivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • meropenem
  • Furoscix (furosemide)
    +
    meropenem
    1 interaction

    Monitor/Modify Tx

    furosemide + meropenem

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport possibly inhibited)

  • mesalamine
  • Furoscix (furosemide)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    furosemide + mesalamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Furoscix (furosemide)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    furosemide + mesalamine rectal

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • metformin
  • Furoscix (furosemide)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    furosemide + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Furoscix (furosemide)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    furosemide + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • methazolamide
  • Furoscix (furosemide)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    furosemide + methazolamide

    monitor potassium, sodium: combo may incr. risk of hypokalemia, hyponatremia (additive effects)

  • methohexital
  • Furoscix (furosemide)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    furosemide + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methotrexate
  • Furoscix (furosemide)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    furosemide + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • methylene blue injection
  • Furoscix (furosemide)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    furosemide + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metolazone
  • Furoscix (furosemide)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    furosemide + metolazone

    monitor renal fxn, potassium, sodium: combo may incr. risk of renal impairment, hypokalemia, hyponatremia, including life-threatening (additive effects)

  • midazolam
  • Furoscix (furosemide)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    furosemide + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mifepristone
  • Furoscix (furosemide)
    +
    mifepristone
    1 interaction

    Monitor/Modify Tx

    furosemide + mifepristone

    monitor potassium if daily mifepristone use: combo may incr. risk of hypokalemia (additive effects)

  • miglitol
  • Furoscix (furosemide)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    furosemide + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milrinone
  • Furoscix (furosemide)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    furosemide + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Furoscix (furosemide)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    furosemide + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirtazapine
  • Furoscix (furosemide)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    furosemide + mirtazapine

    monitor sodium, BP: combo may incr. risk of hyponatremia, hypotension, including orthostasis (additive effects)

  • mitomycin
  • Furoscix (furosemide)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    furosemide + mitomycin

    monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • moexipril
  • Furoscix (furosemide)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    furosemide + moexipril

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • molindone
  • Furoscix (furosemide)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    furosemide + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • morphine
  • Furoscix (furosemide)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    furosemide + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • motixafortide
  • Furoscix (furosemide)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    furosemide + motixafortide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • nabumetone
  • Furoscix (furosemide)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    furosemide + nabumetone

    monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • nalbuphine
  • Furoscix (furosemide)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    furosemide + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • naphazoline ophthalmic
  • Furoscix (furosemide)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + naphazoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Furoscix (furosemide)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    furosemide + naproxen

    monitor renal fxn, BP, ototoxicity: combo may incr. risk of renal impairment, auditory, vestibular adverse effects; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • nateglinide
  • Furoscix (furosemide)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    furosemide + nateglinide

    monitor glucose; consider incr. nateglinide dose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Furoscix (furosemide)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    furosemide + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • necitumumab
  • Furoscix (furosemide)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    furosemide + necitumumab

    monitor potassium, calcium, magnesium: combo may incr. risk of hypokalemia, hypocalcemia, tetany, hypomagnesemia (additive effects)

  • niacin (vitamin B3)
  • Furoscix (furosemide)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    furosemide + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nilotinib
  • Furoscix (furosemide)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    furosemide + nilotinib

    monitor potassium, calcium, sodium: combo may incr. risk of hypokalemia, hypocalcemia, tetany, hyponatremia (additive effects)

  • nitisinone
  • Furoscix (furosemide)
    +
    nitisinone
    1 interaction

    Monitor/Modify Tx

    furosemide + nitisinone

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport inhibited)

  • nitric oxide
  • Furoscix (furosemide)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    furosemide + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Furoscix (furosemide)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    furosemide + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Furoscix (furosemide)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    furosemide + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Furoscix (furosemide)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    furosemide + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Furoscix (furosemide)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    furosemide + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nusinersen
  • Furoscix (furosemide)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    furosemide + nusinersen

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • obinutuzumab
  • Furoscix (furosemide)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    furosemide + obinutuzumab

    monitor BP: combo may incr. risk of hypotension; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olanzapine
  • Furoscix (furosemide)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    furosemide + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Furoscix (furosemide)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    furosemide + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • olmesartan medoxomil
  • Furoscix (furosemide)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    furosemide + olmesartan medoxomil

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • olsalazine
  • Furoscix (furosemide)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    furosemide + olsalazine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • omeprazole
  • Furoscix (furosemide)
    +
    omeprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + omeprazole

    monitor magnesium, especially w/ omeprazole tx >3mo: combo may incr. risk of hypomagnesemia, cardiac arrhythmias, tetany, seizures (additive effects)

  • opicapone
  • Furoscix (furosemide)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    furosemide + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Furoscix (furosemide)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    furosemide + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxaliplatin
  • Furoscix (furosemide)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    furosemide + oxaliplatin

    monitor ECG, CBC, renal fxn, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • oxaprozin
  • Furoscix (furosemide)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    furosemide + oxaprozin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • oxazepam
  • Furoscix (furosemide)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    furosemide + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxcarbazepine
  • Furoscix (furosemide)
    +
    oxcarbazepine
    1 interaction

    Monitor/Modify Tx

    furosemide + oxcarbazepine

    monitor sodium: combo may incr. risk of hyponatremia, seizures (additive effects)

  • oxycodone
  • Furoscix (furosemide)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    furosemide + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • oxymetazoline nasal
  • Furoscix (furosemide)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    furosemide + oxymetazoline nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Furoscix (furosemide)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + oxymetazoline ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline topical
  • Furoscix (furosemide)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    furosemide + oxymetazoline topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymorphone
  • Furoscix (furosemide)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    furosemide + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • ozanimod
  • Furoscix (furosemide)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    furosemide + ozanimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • paliperidone
  • Furoscix (furosemide)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    furosemide + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Furoscix (furosemide)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    furosemide + palopegteriparatide

    monitor BP, calcium: combo may incr. risk of hypocalcemia, tetany, hypotension, including orthostasis, syncope (additive effects)

  • pamidronate
  • Furoscix (furosemide)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    furosemide + pamidronate

    monitor renal fxn, potassium, calcium, magnesium: combo may incr. pamidronate levels, risk of hypokalemia, hypocalcemia, hypomagnesemia, tetany, nephrotoxicity, other adverse effects (additive effects)

  • panitumumab
  • Furoscix (furosemide)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    furosemide + panitumumab

    monitor potassium, calcium, magnesium: combo may incr. risk of hypokalemia, hypocalcemia, hypomagnesemia, tetany (additive effects)

  • pantoprazole
  • Furoscix (furosemide)
    +
    pantoprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + pantoprazole

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • paroxetine
  • Furoscix (furosemide)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    furosemide + paroxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • patiromer
  • Furoscix (furosemide)
    +
    patiromer
    1 interaction

    Monitor/Modify Tx

    furosemide + patiromer

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • pegloticase
  • Furoscix (furosemide)
    +
    pegloticase
    1 interaction

    Monitor/Modify Tx

    furosemide + pegloticase

    monitor uric acid levels: combo may decr. pegloticase efficacy (antagonistic effects)

  • pemetrexed
  • Furoscix (furosemide)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    furosemide + pemetrexed

    monitor CBC, renal fxn: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Furoscix (furosemide)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    furosemide + penicillamine

    monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentamidine
  • Furoscix (furosemide)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    furosemide + pentamidine

    monitor renal fxn, BP, calcium: combo may incr. risk of nephrotoxicity, severe or life-threatening hypotension, hypocalcemia, tetany (additive effects)

  • pentazocine
  • Furoscix (furosemide)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    furosemide + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • pentobarbital
  • Furoscix (furosemide)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    furosemide + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pentostatin
  • Furoscix (furosemide)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    furosemide + pentostatin

    monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentoxifylline
  • Furoscix (furosemide)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    furosemide + pentoxifylline

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perindopril
  • Furoscix (furosemide)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    furosemide + perindopril

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • perphenazine
  • Furoscix (furosemide)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    furosemide + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • phenelzine
  • Furoscix (furosemide)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    furosemide + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Furoscix (furosemide)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    furosemide + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenylephrine nasal
  • Furoscix (furosemide)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    furosemide + phenylephrine nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Furoscix (furosemide)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine rectal
  • Furoscix (furosemide)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    furosemide + phenylephrine rectal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • Furoscix (furosemide)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    furosemide + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • Furoscix (furosemide)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    furosemide + piroxicam

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • polyethylene glycol
  • Furoscix (furosemide)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    furosemide + polyethylene glycol

    monitor volume status, renal fxn, sodium, potassium, consider monitoring ECG, especially if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, dehydration, renal impairment, other adverse effects (additive effects)

  • polyethylene glycol/electrolytes
  • Furoscix (furosemide)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    furosemide + polyethylene glycol/ electrolytes

    monitor renal fxn, volume status, sodium, potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, dehydration, renal impairment, other adverse effects (additive effects)

  • polymyxin B
  • Furoscix (furosemide)
    +
    polymyxin B
    1 interaction

    Monitor/Modify Tx

    furosemide + polymyxin B

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ponesimod
  • Furoscix (furosemide)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    furosemide + ponesimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • posaconazole
  • Furoscix (furosemide)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    furosemide + posaconazole

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • pramipexole
  • Furoscix (furosemide)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    furosemide + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Furoscix (furosemide)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    furosemide + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Furoscix (furosemide)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    furosemide + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pretomanid
  • Furoscix (furosemide)
    +
    pretomanid
    1 interaction

    Monitor/Modify Tx

    furosemide + pretomanid

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport possibly inhibited)

  • primidone
  • Furoscix (furosemide)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    furosemide + primidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • probenecid
  • Furoscix (furosemide)
    +
    probenecid
    1 interaction

    Monitor/Modify Tx

    furosemide + probenecid

    monitor renal fxn, uric acid levels: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects; may decr. probenecid efficacy (renal transport inhibited; antagonistic effects)

  • procarbazine
  • Furoscix (furosemide)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    furosemide + procarbazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • prochlorperazine
  • Furoscix (furosemide)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    furosemide + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Furoscix (furosemide)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    furosemide + promethazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propafenone
  • Furoscix (furosemide)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    furosemide + propafenone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propofol
  • Furoscix (furosemide)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    furosemide + propofol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • protriptyline
  • Furoscix (furosemide)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    furosemide + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quinapril
  • Furoscix (furosemide)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    furosemide + quinapril

    monitor renal fxn, sodium, BP; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • quinidine (antiarrhythmic)
  • Furoscix (furosemide)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    furosemide + quinidine (antiarrhythmic)

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • quinidine (CYP2D6 inhibitor)
  • Furoscix (furosemide)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    furosemide + quinidine (CYP2D6 inhibitor)

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • quinine
  • Furoscix (furosemide)
    +
    quinine
    1 interaction

    Monitor/Modify Tx

    furosemide + quinine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • rabeprazole
  • Furoscix (furosemide)
    +
    rabeprazole
    1 interaction

    Monitor/Modify Tx

    furosemide + rabeprazole

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • ramipril
  • Furoscix (furosemide)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    furosemide + ramipril

    monitor renal function, sodium, BP; consider decrease dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia, hypotension (additive effects)

  • rasagiline
  • Furoscix (furosemide)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    furosemide + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasburicase
  • Furoscix (furosemide)
    +
    rasburicase
    1 interaction

    Monitor/Modify Tx

    furosemide + rasburicase

    monitor uric acid levels: combo may decr. rasburicase efficacy (antagonistic effects)

  • remifentanil
  • Furoscix (furosemide)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    furosemide + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • remimazolam
  • Furoscix (furosemide)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    furosemide + remimazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • repaglinide
  • Furoscix (furosemide)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    furosemide + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • Rho(D) immune globulin
  • Furoscix (furosemide)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    furosemide + Rho(D) immune globulin

    monitor renal fxn; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • riociguat
  • Furoscix (furosemide)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    furosemide + riociguat

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • risedronate
  • Furoscix (furosemide)
    +
    risedronate
    1 interaction

    Monitor/Modify Tx

    furosemide + risedronate

    monitor calcium: combo may incr. risk of hypocalcemia, tetany (additive effects)

  • risperidone
  • Furoscix (furosemide)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    furosemide + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rituximab
  • Furoscix (furosemide)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    furosemide + rituximab

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rocuronium
  • Furoscix (furosemide)
    +
    rocuronium
    1 interaction

    Monitor/Modify Tx

    furosemide + rocuronium

    monitor respiratory rate: combo may incr. risk of respiratory depression, potentiate, prolong neuromuscular blockade (mechanism unknown)

  • romidepsin
  • Furoscix (furosemide)
    +
    romidepsin
    1 interaction

    Monitor/Modify Tx

    furosemide + romidepsin

    monitor electrolytes: combo may incr. risk of hyponatremia, hypomagnesemia, hypocalcemia, tetany (additive effects)

  • romosozumab
  • Furoscix (furosemide)
    +
    romosozumab
    1 interaction

    Monitor/Modify Tx

    furosemide + romosozumab

    monitor calcium, especially w/ concomitant renal impairment: combo may incr. risk of hypocalcemia, tetany (additive effects)

  • ropeginterferon alfa-2b
  • Furoscix (furosemide)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    furosemide + ropeginterferon alfa-2b

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ropivacaine
  • Furoscix (furosemide)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    furosemide + ropivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • rosiglitazone
  • Furoscix (furosemide)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    furosemide + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sacituzumab govitecan
  • Furoscix (furosemide)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    furosemide + sacituzumab govitecan

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sacubitril
  • Furoscix (furosemide)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    furosemide + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Furoscix (furosemide)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    furosemide + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • salsalate
  • Furoscix (furosemide)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    furosemide + salsalate

    monitor renal fxn, ototoxicity, BP w/ high-dose salsalate: combo may incr. risk of renal impairment, auditory, vestibular adverse effects; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • saxagliptin
  • Furoscix (furosemide)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    furosemide + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Furoscix (furosemide)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    furosemide + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Furoscix (furosemide)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    furosemide + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selinexor
  • Furoscix (furosemide)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    furosemide + selinexor

    monitor sodium, potassium: combo may incr. risk of hypokalemia, hyponatremia, including life-threatening (additive effects)

  • semaglutide
  • Furoscix (furosemide)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    furosemide + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sertraline
  • Furoscix (furosemide)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    furosemide + sertraline

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • sevelamer
  • Furoscix (furosemide)
    +
    sevelamer
    1 interaction

    Monitor/Modify Tx

    furosemide + sevelamer

    consider giving oral furosemide at least 1h before or 3h after each sevelamer dose: combo may decr. furosemide levels, efficacy (absorption decreased/delayed)

  • sevoflurane
  • Furoscix (furosemide)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    furosemide + sevoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sildenafil
  • Furoscix (furosemide)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    furosemide + sildenafil

    monitor BP, ototoxicity: combo may incr. risk of hypotension, auditory, vestibular adverse effects (additive effects)

  • silodosin
  • Furoscix (furosemide)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    furosemide + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sirolimus
  • Furoscix (furosemide)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    furosemide + sirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sirolimus albumin-bound
  • Furoscix (furosemide)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    furosemide + sirolimus albumin-bound

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sitagliptin
  • Furoscix (furosemide)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    furosemide + sitagliptin

    monitor glucose, renal fxn: combo may incr. risk of nephrotoxicity; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sodium benzoate
  • Furoscix (furosemide)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium benzoate

    monitor potassium, especially if hyperammonemia use: combo may incr. risk of hypokalemia (additive effects)

  • sodium ferric gluconate complex
  • Furoscix (furosemide)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sodium phenylacetate
  • Furoscix (furosemide)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium phenylacetate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium phenylbutyrate
  • Furoscix (furosemide)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium phenylbutyrate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • sodium phosphate rectal
  • Furoscix (furosemide)
    +
    sodium phosphate rectal
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium phosphate rectal

    monitor electrolytes, volume status: combo may incr. risk of electrolyte abnormalities, dehydration, other adverse effects (additive effects)

  • sodium picosulfate
  • Furoscix (furosemide)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium picosulfate

    monitor electrolytes, volume status: combo may incr. risk of electrolyte abnormalities, dehydration, seizures, cardiac arrhythmias, renal impairment, other adverse effects (additive effects)

  • sodium polystyrene sulfonate
  • Furoscix (furosemide)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium polystyrene sulfonate

    monitor calcium, magnesium, potassium, ECG; separate admin. w/ oral furosemide by at least 3h (6h if gastroparesis); rectal sodium polystyrene sulfonate use OK: combo may incr. risk of hypocalcemia, tetany, hypomagnesemia, hypokalemia, QT prolongation, cardiac arrhythmias; may decr. furosemide levels, efficacy (additive effects; absorption possibly decreased)

  • sodium thiosulfate
  • Furoscix (furosemide)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium; otherwise, caution advised: combo may incr. risk of hypokalemia (additive effects)

  • sodium zirconium cyclosilicate
  • Furoscix (furosemide)
    +
    sodium zirconium cyclosilicate
    1 interaction

    Monitor/Modify Tx

    furosemide + sodium zirconium cyclosilicate

    admin. furosemide at least 2h before or 2h after sodium zirconium cyclosilicate: combo may incr. furosemide levels, risk of hypotension, other adverse effects (absorption increased at higher gastric pH)

  • sotagliflozin
  • Furoscix (furosemide)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    furosemide + sotagliflozin

    monitor BP, electrolytes, volume status, renal fxn: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects (additive effects)

  • sotalol
  • Furoscix (furosemide)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    furosemide + sotalol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sparsentan
  • Furoscix (furosemide)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    furosemide + sparsentan

    monitor BP, renal fxn: combo may incr. risk of nephrotoxicity, hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Furoscix (furosemide)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    furosemide + spironolactone

    monitor renal fxn, sodium: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • streptozocin
  • Furoscix (furosemide)
    +
    streptozocin
    1 interaction

    Monitor/Modify Tx

    furosemide + streptozocin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • succinylcholine
  • Furoscix (furosemide)
    +
    succinylcholine
    1 interaction

    Monitor/Modify Tx

    furosemide + succinylcholine

    monitor respiratory rate: combo may incr. risk of respiratory depression, potentiate, prolong neuromuscular blockade (mechanism unknown)

  • sucralfate
  • Furoscix (furosemide)
    +
    sucralfate
    1 interaction

    Monitor/Modify Tx

    furosemide + sucralfate

    give oral furosemide at least 2h before or after sucralfate: combo may decr. furosemide levels, efficacy (absorption possibly decreased/delayed)

  • sufentanil
  • Furoscix (furosemide)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    furosemide + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • sulfate bowel prep
  • Furoscix (furosemide)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    furosemide + sulfate bowel prep

    monitor renal fxn, volume status, sodium, potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, hyponatremia, seizures, renal impairment, dehydration, other adverse effects (additive effects)

  • sulindac
  • Furoscix (furosemide)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    furosemide + sulindac

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • tadalafil
  • Furoscix (furosemide)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    furosemide + tadalafil

    monitor for ototoxicity, BP: combo may incr. risk of auditory, vestibular adverse effects, hypotension (additive effects)

  • tafasitamab
  • Furoscix (furosemide)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    furosemide + tafasitamab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • tamsulosin
  • Furoscix (furosemide)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    furosemide + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Furoscix (furosemide)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    furosemide + tapentadol

    monitor BP; consider furosemide dose adjustment: combo may increase risk of severe hypotension, including orthostasis, syncope; may decrease furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • taurine
  • Furoscix (furosemide)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    furosemide + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • telavancin
  • Furoscix (furosemide)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    furosemide + telavancin

    monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Furoscix (furosemide)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    furosemide + telmisartan

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • temsirolimus
  • Furoscix (furosemide)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    furosemide + temsirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Furoscix (furosemide)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    furosemide + tenofovir alafenamide

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tenofovir disoproxil
  • Furoscix (furosemide)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    furosemide + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • teprotumumab
  • Furoscix (furosemide)
    +
    teprotumumab
    1 interaction

    Monitor/Modify Tx

    furosemide + teprotumumab

    monitor ototoxicity s/sx: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • terazosin
  • Furoscix (furosemide)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    furosemide + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tetrahydrozoline ophthalmic
  • Furoscix (furosemide)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + tetrahydrozoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thalidomide
  • Furoscix (furosemide)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    furosemide + thalidomide

    monitor calcium, BP: combo may incr. risk of hypocalcemia, tetany, hypotension, including orthostasis (additive effects)

  • thioridazine
  • Furoscix (furosemide)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    furosemide + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Furoscix (furosemide)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    furosemide + thiothixene

    monitor BP: combo may incr. risk of hypotension, syncope (additive effects)

  • timolol ophthalmic
  • Furoscix (furosemide)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    furosemide + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tiopronin
  • Furoscix (furosemide)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    furosemide + tiopronin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tirzepatide
  • Furoscix (furosemide)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    furosemide + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Furoscix (furosemide)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    furosemide + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Furoscix (furosemide)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    furosemide + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolmetin
  • Furoscix (furosemide)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    furosemide + tolmetin

    monitor renal fxn, BP: combo may incr. risk of renal impairment; may decr. furosemide efficacy (additive effects; antagonistic effects)

  • topiramate
  • Furoscix (furosemide)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    furosemide + topiramate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • tramadol
  • Furoscix (furosemide)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    furosemide + tramadol

    monitor sodium, BP: combo may incr. risk of severe hyponatremia, severe hypotension, including orthostasis, syncope; may decr. furosemide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

  • trandolapril
  • Furoscix (furosemide)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    furosemide + trandolapril

    monitor renal fxn, sodium; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • tranylcypromine
  • Furoscix (furosemide)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    furosemide + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Furoscix (furosemide)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    furosemide + trazodone

    monitor sodium, BP: combo may incr. risk of hyponatremia, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Furoscix (furosemide)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    furosemide + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamterene
  • Furoscix (furosemide)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    furosemide + triamterene

    monitor renal fxn, hyponatremia: combo may incr. risk of renal impairment, hyponatremia (additive effects)

  • trifluoperazine
  • Furoscix (furosemide)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    furosemide + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimethoprim
  • Furoscix (furosemide)
    +
    trimethoprim
    1 interaction

    Monitor/Modify Tx

    furosemide + trimethoprim

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport inhibited)

  • trimipramine
  • Furoscix (furosemide)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    furosemide + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vaborbactam
  • Furoscix (furosemide)
    +
    vaborbactam
    1 interaction

    Monitor/Modify Tx

    furosemide + vaborbactam

    monitor renal fxn: combo may incr. furosemide levels, risk of nephrotoxicity, other adverse effects; may decr. furosemide natriuretic effects (renal transport possibly inhibited)

  • vaccinia immune globulin
  • Furoscix (furosemide)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    furosemide + vaccinia immune globulin

    monitor renal fxn; use lowest vaccinia immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • valacyclovir
  • Furoscix (furosemide)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    furosemide + valacyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valganciclovir
  • Furoscix (furosemide)
    +
    valganciclovir
    1 interaction

    Monitor/Modify Tx

    furosemide + valganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • valsartan
  • Furoscix (furosemide)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    furosemide + valsartan

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • vancomycin
  • Furoscix (furosemide)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    furosemide + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • vardenafil
  • Furoscix (furosemide)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    furosemide + vardenafil

    monitor BP, ototoxicity: combo may incr. risk of hypotension, auditory, vestibular adverse effects (additive effects)

  • vecuronium
  • Furoscix (furosemide)
    +
    vecuronium
    1 interaction

    Monitor/Modify Tx

    furosemide + vecuronium

    monitor respiratory rate: combo may incr. risk of respiratory depression, potentiate, prolong neuromuscular blockade (mechanism unknown)

  • vilazodone
  • Furoscix (furosemide)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    furosemide + vilazodone

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • vinblastine
  • Furoscix (furosemide)
    +
    vinblastine
    1 interaction

    Monitor/Modify Tx

    furosemide + vinblastine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • vincristine
  • Furoscix (furosemide)
    +
    vincristine
    1 interaction

    Monitor/Modify Tx

    furosemide + vincristine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • vinorelbine
  • Furoscix (furosemide)
    +
    vinorelbine
    1 interaction

    Monitor/Modify Tx

    furosemide + vinorelbine

    monitor for ototoxicity: combo may incr. risk of auditory, vestibular adverse effects (additive effects)

  • vonoprazan
  • Furoscix (furosemide)
    +
    vonoprazan
    1 interaction

    Monitor/Modify Tx

    furosemide + vonoprazan

    monitor magnesium: combo may incr. risk of hypomagnesemia (additive effects)

  • vortioxetine
  • Furoscix (furosemide)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    furosemide + vortioxetine

    monitor sodium: combo may incr. risk of hyponatremia (additive effects)

  • vosoritide
  • Furoscix (furosemide)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    furosemide + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • willow bark
  • Furoscix (furosemide)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    furosemide + willow bark

    monitor renal fxn, especially w/ high-dose willow bark: combo may incr. risk of renal impairment (additive effects, willow bark may contain salicylates)

  • ziprasidone
  • Furoscix (furosemide)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    furosemide + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • zoledronic acid
  • Furoscix (furosemide)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    furosemide + zoledronic acid

    monitor renal fxn, calcium: combo may incr. zoledronic acid levels, risk of nephrotoxicity, hypocalcemia, tetany, other adverse effects (additive effects)

  • zonisamide
  • Furoscix (furosemide)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    furosemide + zonisamide

    monitor renal fxn, potassium: combo may incr. risk of renal impairment, hypokalemia (additive effects)

Caution Advised

  • acitretin
  • Furoscix (furosemide)
    +
    acitretin
    1 interaction

    Caution Advised

    furosemide + acitretin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • ginseng, Asian
  • Furoscix (furosemide)
    +
    ginseng, Asian
    1 interaction

    Caution Advised

    furosemide + ginseng, Asian

    caution advised: combo may result in diuretic resistance (mechanism unknown)

  • methoxsalen
  • Furoscix (furosemide)
    +
    methoxsalen
    1 interaction

    Caution Advised

    furosemide + methoxsalen

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

  • phenytoin
  • Furoscix (furosemide)
    +
    phenytoin
    1 interaction

    Caution Advised

    furosemide + phenytoin

    caution advised: combo may decr. furosemide levels, efficacy (mechanism unknown)

  • verteporfin
  • Furoscix (furosemide)
    +
    verteporfin
    1 interaction

    Caution Advised

    furosemide + verteporfin

    caution advised: combo may incr. risk of photosensitivity reaction (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@2dfd7ca8
  • hypokalemia, severe
  • electrolyte imbalance, severe
  • arrhythmia
  • metabolic alkalosis
  • hypovolemia
  • dehydration
  • ototoxicity
  • thrombocytopenia
  • hemolytic anemia
  • aplastic anemia
  • leukopenia
  • agranulocytosis
  • eosinophilia
  • thrombosis
  • anaphylaxis
  • vasculitis
  • interstitial nephritis
  • necrotizing angiitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • erythema multiforme
  • drug reaction with eosinophilia and systemic symptoms
  • acute generalized exanthematous pustulosis
  • exfoliative dermatitis
  • pancreatitis
  • cholestatic jaundice
  • SLE exacerbation
  • nephrolithiasis (chronic use in patients <4 yo)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@c5f2259
  • urinary frequency
  • dizziness
  • nausea
  • vomiting
  • weakness
  • muscle cramps
  • hypokalemia
  • hypomagnesemia
  • hypotension, orthostatic
  • ALT or AST elevated
  • blurred vision
  • anorexia
  • abdominal cramps
  • diarrhea
  • pruritus
  • rash
  • infusion site reaction (on-body infusor form)
  • hyperuricemia
  • hyperglycemia
  • hypocalcemia
  • tinnitus
  • paresthesia
  • photosensitivity
  • cholesterol incr.
  • triglycerides incr.

Safety/Monitoring .

Monitoring Parameters
BUN/Cr, serum CO2, electrolytes, uric acid frequently early in tx, then periodically; CBC; Plt; LFTs; urine/blood glucose especially if diabetes or suspected latent diabetes

Look/Sound-Alike Drug Names
furosemide confused with: famotidine; finasteride; fluconazole; FLUoxetine; fosinopril; loperamide; torsemide

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; risk of fetal harm not expected based on limited human data; possible risk of decr. placental perfusion based on drug's mechanism of action

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding, especially in high-risk infants; no human data available, though risk of infant harm not expected based on drug properties; decr. milk production, especially with higher doses, based on limited human data

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@7598293b

Metabolism: for furosemide: liver minimally; CYP450: unknown

Excretion: for furosemide: urine 88%, bile/feces 12%; Half-life: 2h

Subclass: Diuretics, Loop

Mechanism of Action
for furosemide: inhibits loop of Henle and proximal and distal convoluted tubule sodium and chloride resorption

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: scPharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@7d8d1a6a

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information